AZMED

AZmed is a French company founded in 2018 with the aim of improving doctors' working conditions and patient care. The first solution developed, Rayvolve, is a computer-aided diagnosis tool able to detect all types of fractures and chest pathologies on standard X-Rays. It allows radiologists and emergency physicians to save time and reduce the risk of diagnosis errors. Rayvolve is CE marked since 2019 and FDA cleared since 2022. It is 100% integrated into physicians' workflow. It is directly connected to the PACS and the predictions are generated in the same series of exams.

Today, Rayvolve is used in more that 300 healthcare centers across 20 countries.